The DIA Europe 2027 programme is built around collaboration, innovation and sustainability – three key pillars for shaping the future of healthcare. Among various key discussions, sessions will explore how to bring and retain innovation in Europe, improve environmental and systems sustainability across the medicinal products development lifecycle, and how to collaborate effectively to ensure patient access to innovative medicines and other medical products.

From medicines and medicinal products regulation and clinical trials to real-world evidence, digital health, and regulatory innovation, DIA Europe provides a unique platform where the European Medicines Agency (EMA), national competent authorities, industry, HTA bodies, and patient representatives exchange practical solutions to today’s healthcare, regulatory, and policy challenges.